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Abstract: Understanding distinct cell-type specific gene expression in human pancreatic islets is
important for developing islet regeneration strategies and therapies to improve β-cell function
in type 1 diabetes (T1D). While numerous transcriptome-wide studies on human islet cell-types
have focused on protein-coding genes, the non-coding repertoire, such as long non-coding RNA,
including circular RNAs, remains mostly unexplored. Here, we explored transcriptional landscape
of human α-, β-, and exocrine cells from published total RNA sequencing (RNA-seq) datasets to
identify circular RNAs (circRNAs). Our analysis revealed that circRNAs are highly abundant in
both α- and β-cells. We identified 10,830 high-confidence circRNAs expressed in human α-, β-,
and exocrine cells. The most highly expressed candidates were MAN1A2, RMST, and HIPK3 across
the three cell-types. Alternate circular isoforms were observed for circRNAs in the three cell-types,
indicative of potential distinct functions. Highly selective α- and β-cell circRNAs were identified,
which is suggestive of their potential role in regulating β-cell function.
Keywords: circular RNAs; circRNA; human islets; RNA-seq; type 1 diabetes; β-cell
1. Introduction
The emergence of non-coding RNAs as essential players in the regulation of gene expression
has advanced our understanding of many cellular processes and provided novel mechanistic
insights into various pathophysiological conditions [1]. In the last decade, non-coding RNAs,
including microRNAs and long non-coding RNAs (lncRNAs), have been implicated in various diseases,
such as cancers, neurological disorders, and autoimmune diseases [2–6]. Circular RNAs (circRNAs)
are a repertoire of a newly discovered class of endogenous non-coding RNAs that are characterized
by covalently linked 3′ and 5′ ends through a backsplicing process to form a closed loop circular
structure, hence named circular RNAs. circRNAs are generally formed by alternative splicing of
pre-mRNA and do not possess a 5′ cap or a 3′ Poly A tail, a characteristic feature of mRNAs [7–11].
circRNAs are a highly abundant, conserved, stable, and highly regulated phenomenon across
many species [12,13]. Their ubiquitous as well as cell-type specific expression has been independently
confirmed by high throughput sequencing of the ribonuclease (RNase) R treated RNA combined
with informatics algorithms to characterize circRNAs by detecting back-spliced junctions [13,14].
A number of studies have shown that circRNAs are expressed independent of their cognate linear
mRNA [11,15,16]. The circRNA levels (as measured by circRNA-specific junction counts) do not
correlate with the overall abundance of the corresponding mRNA [11,14–16]. circRNAs have
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been found enriched in neuronal tissues and exhibit dynamic expression patterns during various
developmental stages [12,17–21].
Although, in the past few years, the number of circRNAs with known biological functions has rapidly
grown, for a large majority of circRNAs, their functions remain unknown. Several studies have shown
circRNAs can function as competing endogenous RNAs (ceRNAs) or microRNA (miRNA) sponges [22–24].
For example, CDR1as or ciRS-7 contains more than 70 conserved binding sites for miRNA-7 [22,23]
and is involved in regulating insulin content and secretion in mouse pancreatic islets [24]. circ-SRY is
another important circRNA exclusively found expressed in mice testis and contains 16 binding sites for
miRNA-138 [23]. Other examples of circRNAs known to act as miRNA sponges include: Circ-ITCH [25],
circHIPK3 [26], hsa_circ_0000615 [27], and mm9_circ_012559 [28]. CircRNAs have also been suggested
to exert their function through-interaction with RNA binding proteins (RBPs), e.g., circ-Foxo3 [29]
circ-MBL (muscleblind) [30]; and by modulating mRNA stability by circRNA–mRNA duplex formation,
e.g., ciRS-7–CDR1 [31], circ-RasGEF1B-ICAM-1 [32]. Additionally, circRNAs also regulate the transcription
of their host genes. For example, circ-EIF3J, circ-PAIP2, ci-ankrd52, and ci-sirt7 are involved
in regulating the transcription of their host genes through interaction with RNA Pol II [33,34].
Interestingly, some circRNAs, such as circ-ZNF609 and circMbl3, are translated into proteins [35,36].
A large number of studies reported dysregulation of circRNAs in various cancers,
including gastric [37,38], colon [39,40], lung [41,42], leukemia [43], and hepatocellular carcinomas [44–46].
circRNAs are also implicated in type 1 and type 2 diabetes and their related complications [47–51].
For example, Shan K et al. [47] studied the role of circRNAs in diabetic retinopathy and observed
significant upregulation of circHIPK3 in diabetic retinas and retinal endothelial cells. circHIPK3 silencing
in vivo decreased retinal acellular capillaries, vascular leakage, and inflammation and, overall, led to
improved retinal vascular dysfunction [47]. The authors further demonstrated that circHIPK3 acted
as an endogenous sponge to sequester and inhibit miR-30a-3p activity. In another study, Circ_0054633
was identified as a potential diagnostic biomarker of pre-diabetes and type 2 diabetes in peripheral
blood [48]. circRNA Cdr1as regulated insulin transcription and secretion in islet cells via miR-7 and its
targets [24]. Overexpression of Cdr1as increased insulin secretion and content in MIN6 and mouse
islet cells, leading to an overall improved β-cell function [24]. The expression of circANKRD36
was upregulated in peripheral blood leucocytes of patients with type 2 diabetes and correlated
with chronic inflammation in type 2 diabetics [49], thus suggesting its potential as a biomarker for
screening chronic inflammation in type 2 diabetic patients. A number of circRNAs were found
aberrantly expressed in the placental villi of gestational diabetes patients compared to controls [50].
Recently, Stoll and colleagues used microarray profiling and identified thousands of circRNAs in
human pancreatic islets and confirmed dysregulation of ciRS-7 and circHIPK3 in type 2 diabetes mouse
models [51].
Pancreatic islets are a heterogeneous agglomeration of at least four distinct hormone-secreting
cell types: β, α, δ, γ, and few ε cells [52,53]. These heterogeneous clusters of cells are essential to
the diabetes pathophysiology as they function in synergy and elicit concerted, but distinct, responses to
maintain glucose homeostasis in the body. The cellular heterogeneity of pancreatic islets poses
its own set of challenges, since each of these cell types are known to have distinct epigenetic
and transcriptomic signatures [54–58]. Transcriptome profiling of islets may mask cell-specific
transcriptomic signatures, which could offer important cues to advance our molecular understanding of
events that lead to islet (dys)function [55–59]. Early RNA sequencing (RNA-seq) based transcriptomic
profiling studies have specifically focused on cataloging and characterizing the annotated mRNAs,
miRNAs, and lncRNAs using human, mouse, or rat islets and insulin producing β-cell lines [60–62].
Nonetheless, no study has been undertaken to profile circRNAs’ abundance within each cell-type
of human islets. In this study, we sought to decipher the transcriptional landscape of circRNAs,
leveraging published RNA-seq datasets of FACS-sorted human α-, β-, and exocrine cells. We identified
a cell type-selective repertoire of circRNAs in these three cell types as well as observed alternate
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circularization events. The circRNAs identified in this study could serve as an important resource for
future studies on β-cell function in relation to both type 1 and type 2 diabetes.
2. Results
2.1. Wide-Spread Expression of circRNAs in α- and β-Cells
To explore the circRNA transcriptome of different cell-types in pancreatic islets, we used
the RNA-seq dataset of Bramswig et al. [56] and Ackermann et al. [57] that contained α-, β-cells,
and exocrine cells from eight human donors. This is the only non-polyA+ dataset generated on
human islets so far available, which allowed us to identify circRNAs. For α- and β-cells, eight replicates
per cell-type were included in the analysis, while for the exocrine cells, only two replicates were available.
Each sample had a sequencing depth of at least 30 million reads, sequenced single-end with a length
of 100 bases (Table S1). On average, α-, β-, and exocrine samples had 57, 64, and 99 million reads,
respectively (Table S1).
Tophat-fusion and CIRCexplorer2 [63] were used for circRNA identification. CIRCexplorer
allows fast and accurate detection of circRNAs by detecting back-spliced junction reads from
RNA-seq data and has a very low false positive rate [64,65]. A cutoff of ≥2 junction spanning
reads in at least one sample of a specific cell-type population was used to identify circRNAs.
The intronic circRNAs candidates were excluded from the analysis and only exonic circRNAs were
considered as true candidates. Considering back-splices and selected subset of exonic circRNAs
with ≥2 junction spanning reads, the total number of circRNAs expressed per sample is shown
(Figure 1A). In total, 17,666, 20,387, and 2575 unique exonic circRNAs (with ≥2 junction reads)
were detected in α-, β-cells, and exocrine samples, respectively. Collectively, 28,397 unique
circRNAs were detected in all samples from the three cell-types.
To filter out low expressed candidates, we selected for high confidence circRNAs in α-cell
(n = 7667), β-cell (n = 8396), and exocrine-cell (n = 456) based on an arbitrary cutoff of expression in ≥2
samples and≥2 junction spanning reads in each cell-population (Table 1 and S2). In total, 10,832 unique
high confidence circRNAs (transcribed from 3833 genes) were identified in all samples and 382
candidates were shared among the three cell-types (Figure 1B). These candidates were then compared
to already annotated circRNAs as catalogued in circBase [66] and CircNet [67]. A majority (94%)
of the high confidence circRNAs identified in our study were found to be annotated by CircNet
and circBase with the exact same exonic boundaries (Figure 1C). This overlap further confirms the high
true positive rate among the high confidence circRNAs. The shared highly expressed circRNAs in
α- and β-cells were identified based on an average of >100 junction spanning reads. Table 2 shows
the highly expressed circRNAs, along with their average junction spanning read counts in both
α- and β-cells and their corresponding host gene names. The host genes for these highly expressed
circRNAs included MAN1A2, RMST, HIPK3, and RHOBTB3 (Table 2). MAN1A2, HIPK3, and RHOBTB3
were also expressed in exocrine cells, although at lower levels (an average of 50–80 junction
spanning reads).
Table 1. High confidence circular RNAs (circRNAs) in α-, β-, and exocrine cells. The high confidence
circRNAs were selected based a criterion of expression in ≥2 samples and ≥2 junction spanning reads.
circRNAs Genes
α-Cells 7667 3141
β-Cells 8396 3291
Exocrine-cells 456 388
Common circRNAs 382 332
Total 10,830 3833
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1 
 
 
  Figure 1. Circular RNA (circRNA) distribution in α-, β-, and exocrine cells. The figure shows
(A) the total number of circRNAs expressed per sample, (B) the overlap between the high confidence
circRNAs in α-cell (n = 7667), β-cell (n = 8396) and exocrine-cell (n = 456) and (C) the overlap with
known circRNAs from CircNet and circBase.
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Table 2. Highly expressed circRNAs in α- and β-cells. The highly expressed candidates with
an average of >100 junction spanning reads in α- and β-cells are listed along with their annotations
and expression levels.
circRNA ID Gene Name Average Junction Reads(α-Cells)
Average Junction Reads
(β-Cells) circBase ID
1:117402185:117420649 MAN1A2 267 354 hsa_circ_0000118
12:97492460:97561047 RMST 354 220 -
11:33286412:33287511 HIPK3 263 286 hsa_circ_0000284
4:152411302:152412529 FBXW7 285 241 hsa_circ_0001451
5:95755395:95763620 RHOBTB3 137 307 hsa_circ_0007444
4:143543508:143543972 SMARCA5 180 228 hsa_circ_0001445
7:100023418:100024307 ZKSCAN1 220 177 hsa_circ_0001727
10:31908171:31910563 ARHGAP12 174 167 hsa_circ_0000231
7:24623665:24668660 MPP6 134 144 hsa_circ_0001686
18:9182381:9221999 ANKRD12 101 123 hsa_circ_0000826
2:50921868:50925955 NRXN1 106 110 hsa_circ_0001004
2.2. Genomic Features of circRNAs in α- and β-Cells
We next investigated various genomic features of high confidence circRNAs in α- and β-cells.
The chromosomal distribution of circRNAs in α- and β-cells (Figure 2A) was found to be similar
to other coding and non-coding genes. The α-cell (n = 7667) and β-cell (n = 8396) high confidence
circRNAs were associated to 3141 and 3291 annotated genes, respectively, with two circRNAs per gene
on average. The average length for identified circRNAs was 731 and 717 nucleotides for α- and β-cells,
respectively. Overall, there was no significant difference in the genomic features of circRNAs in α-
and β-cells.
Around 42% of circRNAs in α- and β-cells contained 1 to 3 exons (Figure 2B). The total number
of exons for circRNAs ranged from 1 to 30 and 1 to 43 in α- and β-cells, respectively. We calculated
the exon lengths for each circRNA and found that circRNAs with single exons had longer exon
length in both α- and β-cells as compared to circRNAs with multiple exons (Figure 3). This suggests
that for the back-splicing process, a certain length might be required to maximize exon circularization.
Indeed, a similar observation in relation to exon lengths has been reported by Song et al. [68].
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Figure 2. Genomic features of circRNAs in α- and β-cells. The figure shows (A) the chromosomal
distribution of circRNAs, (B) total number of back-spliced exons in circRNAs, and (C) number of
alternate circularization events per gene in α- (blue) and β- (red) cells.
Figure 3. Exon lengths of circRNAs in α- and β-cells. circRNAs with single exons had longer exon
lengths in both (A) α-cells and (B) β-cells as compared to circRNAs with multiple exons.
2.3. Alternative Circular Isoforms
Alternative circularization events per gene were detected for both α- and β-cells. In β-cells,
1 to 42 alternate circular isoforms per gene were detected with 68% of the host genes having a maximum
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of 2 alternate circular isoforms (Figure 2C). In the case of α-cells, a similar trend was observed with
1 to 39 alternate circular isoforms per gene and 70% of the host genes with up to 2 alternate circular
isoforms (Figure 2C). In both α- and β-cells, approximately 30% of the genes generated only a single
circular variant. The host gene, PTK2, had the highest number of alternate circular isoforms with
39, 42, and 2 isoforms in α-cells, β-cells, and exocrine cells, respectively. The host gene, MAN1A2,
with the highly expressed circRNA candidate, also had other alternate isoforms, (7, 10, and 5 isoforms
in α-, β-, and exocrine cells, respectively). These results highlight that alternate circular isoforms are
highly abundant in α- and β-cells.
2.4. Differentially Expressed circRNAs in β-Cells
To identify differentially expressed circRNAs in β-cells compared to α-cells, circRNAs were
filtered based on expression in at least 25% of the samples and ≥2 junction spanning reads.
In total, 6566 circRNA candidates were retained in α- and β-cell libraries after filtering. For most
of the samples, on average of 25,000 and 30,000 junction reads were observed in α- and β-cells,
respectively (Figure 4A). The differentially expressed circRNAs were identified using a criteria of
abs(log2FC) = 1 and adjusted p-value < 0.05. Figure 4B shows a smear plot of differentially expressed
candidates highlighted in red dots. In total, 36 candidates (from 30 host genes) were differentially
expressed, and of these, 22 circRNAs were upregulated and 14 were downregulated in β-cells (Table 3).
circRNA-TGFBR3 (provisional id: 1:91861470:91861644) was the most highly up-regulated
circRNA in β-cells with a log2FC of 6.14. Previous studies have shown that TGFBR3 is highly β-cell
selective [57]. Moreover, multiple studies have found circRNA-TGFBR3 expressed in different cell-lines
and tissues (CircNet ID: hsa-circ-TGFBR3.25 and circBase ID: hsa_circ_0006622). Out of the two circular
isoforms for TGFBR3 detected in β-cells, 1:91861470:91861644 was the most highly expressed.
We next investigated how expression levels of differentially expressed circRNAs correlate with
expression profiles of their corresponding mRNAs. Figure 5 shows the expression patterns of
the 36 differentially expressed circRNAs and their corresponding 30 host mRNAs. The Pearson’s
correlations (r) were calculated for circRNAs and their host genes using log transformed read
counts (logRC). On average, moderate positive correlations (r = 0.65) were observed between linear
and circRNAs isoforms in combined α- and β-cell samples (Table S3). As shown in the heatmap,
both α- and β-cell circRNAs show highly selective expression patterns as compared to their linear
forms, which were expressed across the two cell-types. Based on this observation, we focused on
cell-specific correlations. For up and down-regulated circRNAs, β-cell and α-cell samples were
used, respectively, to compute cell-specific correlations. Moderate positive correlations (r = 0.5)
were observed for both up and down-regulated circRNAs. Among the up-regulated circRNAs, five out
of 11 host gene vs. circRNA correlations were significant (p-value < 0.05, r ≈ 0.7). In the case of
down-regulated circRNAs, six out of 19 host gene vs. circRNAs correlations were significantly positive
(r ≈ 0.8).
Table 3. Differentially expressed circRNAs in β-cells compared to α-cells. In total, 14 downregulated
and 22 upregulated circRNAs were identified in β-cells using a cutoff of logFC ≥ 1 and adjusted
p-value < 0.05.
circRNA Gene Name Isoform Name logFC p-Value adj. p-Value
Down-Regulated
2:162183413:162203145 FAP ENST00000627638 −6.34 4.40 × 10−8 7.23 × 10−5
2:190895151:190931637 GLS ENST00000320717 −5.67 5.97 × 10−6 3.92 × 10−3
2:200329430:200419496 SPATS2L ENST00000409718 −5.34 4.09 × 10−5 1.22 × 10−2
11:101062446:101126158 PGR ENST00000325455 −5.22 7.83 × 10−5 1.98 × 10−2
5:95906522:95919545 ELL2 ENST00000237853 −5.07 1.77 × 10−4 3.53 × 10−2
8:61633682:61653660 ASPH ENST00000379454 −5.03 2.26 × 10−4 4.24 × 10−2
9:110972072:110973558 LPAR1 ENST00000374431 −4.07 2.45 × 10−9 1.61 × 10−5
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Table 3. Cont.
circRNA Gene Name Isoform Name logFC p-Value adj. p-Value
Down-Regulated
2:190900563:190924593 GLS ENST00000320717 −3.25 4.03 × 10−8 7.23 × 10−5
2:190895151:190910321 GLS ENST00000320717 −3.19 1.65 × 10−4 3.39 × 10−2
10:94030682:94032252 PLCE1 ENST00000260766 −3.11 2.67 × 10−5 1.03 × 10−2
2:190900563:190931637 GLS ENST00000320717 −3.06 3.98 × 10−5 1.22 × 10−2
5:16779544:16783469 MYO10 ENST00000274203 −2.74 5.29 × 10−5 1.51 × 10−2
1:176594523:176595595 PAPPA2 ENST00000367661 −2.74 5.93 × 10−5 1.56 × 10−2
1:95143890:95151419 TMEM56 ENST00000370203 −2.61 9.18 × 10−5 2.08 × 10−2
Up-regulated
1:91861470:91861644 TGFBR3 ENST00000212355 6.14 3.16 × 10−7 3.46 × 10−4
7:18666212:18666476 HDAC9 ENST00000461159 6.07 4.91 × 10−7 4.24 × 10−4
7:14607433:14673027 DGKB ENST00000399322 5.56 1.41 × 10−5 7.13 × 10−3
16:77816920:77825461 VAT1L ENST00000302536 5.49 2.17 × 10−5 8.90 × 10−3
4:42485495:42524847 ATP8A1 ENST00000381668 5.42 3.33 × 10−5 1.18 × 10−2
9:70761600:70784279 TRPM3 ENST00000377110 5.33 5.62 × 10−5 1.54 × 10−2
9:70681505:70784279 TRPM3 ENST00000377110 5.25 9.04 × 10−5 2.08 × 10−2
13:69940039:69975802 KLHL1 ENST00000377844 5.23 9.71 × 10−5 2.12 × 10−2
7:22291174:22318037 RAPGEF5 ENST00000344041 5.15 1.43 × 10−4 3.02 × 10−2
9:76703336:76713721 PRUNE2 ENST00000376718 5.11 1.85 × 10−4 3.58 × 10−2
1:65913244:65918835 PDE4B ENST00000329654 5.09 3.28 × 10−8 7.23 × 10−5
X:154789953:154792285 MPP1 ENST00000369534 5.05 2.37 × 10−4 4.33 × 10−2
7:75943781:75943916 SNORA14A ENST00000364773 4.46 3.13 × 10−7 3.46 × 10−4
8:69755423:69761875 SLCO5A1 ENST00000260126 4.44 3.25 × 10−6 2.37 × 10−3
7:14574211:14673027 DGKB ENST00000399322 4.27 1.62 × 10−5 7.60 × 10−3
13:26337566:26353880 CDK8 ENST00000536792 4.10 6.81 × 10−6 4.06 × 10−3
2:144208602:144211579 GTDC1 ENST00000392869 4.02 3.42 × 10−5 1.18 × 10−2
1:58506059:58539310 OMA1 ENST00000371226 3.93 2.17 × 10−5 8.90 × 10−3
8:32595827:32616885 NRG1 ENST00000523534 3.66 4.06 × 10−5 1.22 × 10−2
18:62348167:62349937 TNFRSF11A ENST00000269485 3.27 8.98 × 10−5 2.08 × 10−2
4:186706562:186709845 FAT1 ENST00000441802 3.11 5.17 × 10−7 4.24 × 10−4
8:69738039:69761875 SLCO5A1 ENST00000260126 2.89 7.85 × 10−6 4.29 × 10−3
 
4 
 
  Figure 4. Distribution of junction spanning reads and smear plot of differentially expressed circRNAs.
(A) Total circRNA junction spanning reads per sample for the high confidence circRNA candidates in
α- and β-cells; (B) A smear plot highlighting differentially expressed candidates (as red dots) in β-cells
when compared to α-cells.
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Figure 5. Expression profiles of differentially expressed candidates. Heatmap of normalized expression
(log2 RC) of differentially expressed circRNAs (A) and their host mRNAs (B) in α- and β-cells.
2.5. Selectively Expressed circRNAs in α- and β-Cells
Selectively expressed circRNAs, including multiple isoforms from specific gene loci,
were identified in α-, β-, and exocrine cells. The circRNA exon-boundaries were intersected in
the three cell-types, and those candidates that overlapped by a maximum of 1 bp were excluded.
To filter lowly expressed candidates, only those candidates expressed in at least 50% of the samples
in each cell-type were considered. Further, circRNAs were filtered by excluding those loci where
an alternate circRNA isoform was present in another cell-type. Based on this analysis, 392, 417,
and 57 selectively expressed circRNAs were identified in α-, β-, and exocrine cells, respectively.
Table 4 shows the number of selectively expressed circRNAs and their corresponding host genes.
The top highly and selectively expressed circRNAs and their features are highlighted (Table 5).
Leveraging on the integrated ATAC-seq and RNA-seq analysis by Ackermann et al [57],
we classified highly selective circRNAs based on the most highly and selectively expressed transcripts
in α- and β-cells. In their analysis, 33 α-cell-selective and 35 β-cell-selective transcripts were identified
as the most highly and selectively expressed (defined as ≥10-fold expression difference between
α- and β-cells, with false discovery rate (FDR) < 0.05). Several of these α- and β-cell enriched loci
were found among our selectively expressed circRNAs (Table 6). These included TGFBR3, which is
highly β-cell selective, and FAP, SYTL5, PTPRT, STK32B, and BVES, which are highly α-cell selective
transcripts. These six loci and their respective circRNAs were labeled highly selective (Table 6).
Table 4. Selectively expressed circRNAs in human islets. The number of selectively expressed
circRNAs and highly selective circRNAs are listed along with the total number of host genes.
Highly selective circRNAs are those that originate from the most highly and selectively expressed
transcripts in each cell type.
Selectively Expressed circRNAs Highly Selective circRNAs
circRNAs Genes circRNAs Genes
α-Cell 392 343 7 5
β-Cell 417 359 1 1
Exocrine cells 57 52 - -
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Table 5. Top highly and selectively expressed circRNAs for α-, β-, and exocrine cells. The averaged
log-transformed junction read counts (log2(RC) are shown as a measure of normalized expression for
each circRNA. Other columns include the total number of exons for each circRNA as represented by
exon Count, circRNA length, and host gene name and biotype.
Gene Name circ ID Exon Count circRNA Length log2(RC) Gene Biotype
α-cell selective circRNAs
PLCE1 10:94030682:94032252 1 1570 4.43 protein_coding
FAP 2:162183413:162203145 9 822 3.38 protein_coding
KANK1 9:710803:713464 1 2661 3.27 protein_coding
MCU 10:72715110:72715902 2 165 3.02 protein_coding
C1orf168 1:56787174:56792803 3 944 2.95 protein_coding
FRMPD3 X:107526581:107533550 3 304 2.93 protein_coding
PLCE1 10:94245945:94246621 1 676 2.88 protein_coding
KIAA1217 10:24219625:24219909 1 284 2.70 protein_coding
SYTL5 X:38033533:38034008 1 475 2.70 protein_coding
FAM126A 7:22960255:22991139 9 1019 2.64 protein_coding
SPG21 15:64974601:64983593 4 476 2.55 protein_coding
POU6F2 7:39204234:39207620 2 321 2.55 protein_coding
PITPNB 22:27894554:27914347 6 436 2.52 protein_coding
PRKCE 2:46001403:46010517 4 614 2.49 protein_coding
SPATS2L 2:200329430:200419496 5 517 2.49 protein_coding
β-cell selective circRNAs
SNORA14A 7:75943781:75943916 1 135 4.96 snoRNA
PDE4B 1:65913244:65918835 2 351 4.37 protein_coding
TNFRSF11A 18:62348167:62349937 2 208 4.21 protein_coding
NRG1 8:32595827:32616885 4 402 3.95 protein_coding
SNORD9 14:21392149:21392253 1 104 3.63 snoRNA
DGKB 7:14574211:14673027 8 738 3.58 protein_coding
GTDC1 2:144208602:144211579 2 267 3.48 protein_coding
SYNE2 14:63998913:64022863 12 2284 3.39 protein_coding
HDAC9 7:18666212:18666476 1 264 3.36 protein_coding
TNRC6B 22:40117054:40156182 3 233 3.36 protein_coding
TGFBR3 1:91861470:91861644 1 174 3.29 protein_coding
NRD1 1:51827795:51834170 2 228 3.29 protein_coding
GLCCI1 7:8003907:8060248 4 509 3.21 protein_coding
ROR1 1:64009304:64050716 3 391 3.04 protein_coding
TSNAX 1:231537212:231542611 2 246 2.88 protein_coding
Exocrine-cell selective circRNAs
SNORD26 11:62855291:62855366 1 75 5.82 snoRNA
PNLIPRP2 10:116625945:116627874 3 373 4.78
polymorphic
_pseudogene
CFTR 7:117504252:117559655 10 1531 4.29 protein_coding
C15orf38-AP3S2 15:89903215:89910819 4 580 4.29 protein_coding
PNLIPRP2 10:116625945:116631357 5 613 4.21
polymorphic
_pseudogene
RAB3D 19:11335446:11335783 2 244 4.13 protein_coding
SEL1L 14:81492479:81495137 2 126 3.81 protein_coding
TRHDE 12:72562164:72575542 5 533 3.64 protein_coding
TRHDE 12:72562852:72575542 4 467 3.52 protein_coding
SLC7A6 16:68266592:68266721 1 129 3.09 protein_coding
IKBKB 8:42325969:42329214 2 219 3.09 protein_coding
SLC43A1 11:57491223:57491862 3 322 3.09 protein_coding
C3orf52 3:112109542:112113145 2 253 2.91 protein_coding
ARF4 3:57583897:57584464 2 191 2.91 protein_coding
SNORD58B 18:49491663:49491729 1 66 2.91 snoRNA
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Table 6. Highly selective α- and β-cell circRNAs are highlighted based on the overlap with integrated
ATAC-seq and mRNA-seq analysis from [57].
α-Cell-Selective circRNAs
Gene Name CHR circ ID circBase or CircNet Id log2(RC)
FAP 2 2:162183413:162203145 hsa-circ-FAP.15 3.4
SYTL5 X X:38033533:38034008 hsa-circ-SYTL5.3 2.7
PTPRT 20 20:42448219:42472562 hsa-circ-PTPRT.2, hsa_circ_0060424 1.9
PTPRT 20 20:42350627:42352285 hsa-circ-PTPRT.5 1
PTPRT 20 20:42756461:42791466 hsa-circ-PTPRT.15 0.2
STK32B 4 4:5139904:5168450 hsa-circ-STK32B.6, hsa_circ_0004536 0.5
BVES 6 6:105115685:105125578 hsa-circ-BVES.2, hsa_circ_0077527 0.3
β-cell-selective circRNAs
TGFBR3 1 1:91861470:91861644 hsa-circ-TGFBR3.25, hsa_circ_0006622 3.3
2.6. Functional Annotation of α- and β-Cell Selective circRNAs
Gene ontology (GO) based functional annotation analysis was performed on the host genes
that produce α- and β-cell selective circRNAs. In total, 359 host genes for β-cell selective
circRNAs and 343 host genes for α-cell selective circRNAs were included in the analysis (referred to
as cluster 1 and cluster 2).
For both clusters, common as well as cluster-specific GO biological processes (BP) terms were
identified. Overall, cluster 1 and 2 showed enrichment for 11 and 12 terms, respectively. We also
identified 10 enriched GO-terms common between the two clusters (as shown in grey nodes in Figure 6).
Similar GO-terms were grouped and one term for each group based on the p-value significance
was selected and highlighted in bold (Figure 6). The α-cell specific GO-terms included regulation of
protein localization to plasma membrane, insulin receptor signaling, ERBB signaling, and regulation of
sodium ion transmembrane transporter activity. In the case of β-cells, five groups of β-cell specific
GO-terms were observed that included cyclic nucleotide catabolic processes, regulation of translation,
tRNA metabolic processes, regulation of translation initiation, and transport along microtubule.
The unspecific (common terms) for both cell-types included cellular response to insulin stimulus
pathway, cell projection assembly, lipid phosphorylation, and autophagosome assembly. Of note,
since the significant GO terms identified in the analysis reflect the host gene function, the relative
contribution of cell-selective expression of circRNAs to the significant GO terms still remains to
be established.
For the highly β-cell selective circRNA-TGFBR3, we created a circRNA-mRNA-miRNA network
using the CircNet database [67]. As shown (Figure 7), circRNA-TGFBR3 might negatively regulate
miR-29a-5p, miR-518a-5p, miR-499a-5p, miR-617, and miR-874-3p. Only the top five miRNAs
with perfectly aligned miRNA binding sites found on the circRNA sequence are shown (Figure 7).
Using the published miRNA expression profiles of human islets and FACS sorted α- and β-cells,
the expression of circRNA-TGFBR3 associated miRNAs was evaluated [69,70]. Based on the miRNA-seq
profiles from [69], two miRNAs, miR-29a-5p and miR-874-3p, were confirmed to be expressed in both
human islets and β-cells (averaged read counts in β-cells: 52 and 1583, respectively). The qPCR profiling
of miRNAs in FACS sorted β-cells [70] also confirmed expression of both miR-29a-5p and miR-874-3p in
β-cells (average CT value of 28 and 30, respectively). The miRNA binding site for hsa-miR-29a-5p within
circ-TGFBR3 is shown as Figure S2.
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Figure 7. circ-TGFBR3.25 with sponge effect on miRNAs as predicted by CircNet. Yellow nodes
represent miRNAs, blue nodes represent genes, and pink nodes represent circRNA. Red edges
represent negative regulation of miRNA to the target gene; blue edges represent negative regulation of
circRNA to miRNAs.
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3. Discussion
In both type 1 and type 2 diabetes, islet dysfunction is a key feature. Genome wide association
studies have shown that most risk loci in type 2 as well as a substantial part in type 1 diabetes are
implicated in islet function [71,72], suggesting that deranged islet cell function is a key culprit in
diabetes. Despite many years of intense research, the exact role of the different islet cell populations
in islet pathophysiology remains elusive. A deeper understanding of the islet anatomy and how this
affects type 1 and type 2 diabetes development is likely to inform the pathogenesis and be important
for the development of new treatment modalities.
Recent studies have identified α- and β-cell selective transcriptomic signatures in
human islets [54–58]. Various regulatory elements, including islet transcription factors and non-coding
RNAs, including lncRNAs, have been reported as essential components for the active maintenance
of adult β-cell identity as well as function [73–75]. It is plausible that circRNAs might play similar
roles in maintaining the β-cell identity and function. Recently, Stoll et al. detected ≈3000 circRNAs in
human islets using a microarray-based approach that covered only a fraction of previously annotated
circRNAs [51]. In this study, we detected ≈10,000 circRNAs in human α-, β-, and exocrine cells using
published high-depth RNA-seq datasets. A majority of the detected circRNAs were mainly expressed
in α, and β-cells, as compared to exocrine cells. This observation agrees with other studies reporting
enrichment of circRNAs in neuro-endocrine tissues [17–20]. However, it cannot be ruled out whether
the low number of circRNAs detected in exocrine cells in this study is likely due to the small sample size
(n = 2) compared to endocrine cells (n = 8).
The most highly expressed circRNAs identified in this study included MAN1A2 and HIPK3,
both exhibiting alternate circular isoforms in the three cell-types under study. Previously, expression of
linear HIPK 3 has been found to be decreased in type 2 diabetes patients and in ob/ob and db/db
mice [51,76]. Moreover, expression of circ-HIPK3 was also decreased in islets of db/db mice
and knockdown of circ-HIPK3 resulted in increased apoptosis and decreased β-cell proliferation [51].
It still remains to be elucidated whether this decrease in circ-HIPK3 expression is associated with β-cell
survival in human islets or human β-cell-line.
Most of the highly-expressed circRNAs in different tissues and cell-lines have been reported to
exist as single isoforms [77]. Only a small fraction of circRNAs are generated in multiple isoforms,
with a majority of these isoforms being expressed at low levels [8,77,78]. These findings suggest
that the majority of host genes produce only one or two highly expressed circRNA isoforms with
functional implications. In both α- and β-cells, 30% of the genes produced single circular isoforms.
Host genes associated with the most number of alternate circularization events as well as those
producing single isoforms warrant further investigations to inform our understanding of circRNA’s
regulatory functions.
The differential expression analysis identified 14 downregulated and 22 upregulated circRNAs in
β-cells compared to α-cells. The highly upregulated circRNAs in β-cells included TGFBR3
and HDAC9 while the highly downregulated circRNAs included FAP and GLS. Of note, most of
the differentially expressed circRNAs did not show any significant correlation with their linear
transcripts. Previous studies have reported similar findings with no significant correlations between
linear and circRNAs isoforms in different tissues [14,15]. Alternative methods targeted to specific
circRNAs (e.g., custom microarrays or RNAase-R treatment prior to RNA-seq) might provide more
accurate estimates for the low abundance, differentially expressed circRNAs.
Although total RNA-seq allows profiling of both coding and non-coding transcripts,
including circular forms, low abundant transcripts are often missed due to a low read depth [79].
The numbers of circRNAs identified in our study are far from complete as conceivably low abundant
circRNA transcripts were most likely missed. To overcome this limitation, future studies are warranted
to profile circRNAs based on enrichment methods, for example, RNase R treatment followed by
Polyadenylation and poly(A)+ RNA Depletion (RPAD) [80].
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We postulate that the selectively expressed circRNAs identified in this study,
including circ-TGFBR3 (provisional id: 1:91861470:91861644), a highly β-cell selective circRNA,
might be involved in maintaining the cell identity and regulating cell-specific processes. Importantly,
TGFBR3 locus encodes the transforming growth factor (TGF)- β type III receptor that often
functions as a co-receptor with other TGF-β receptor superfamily members and is involved in
TGF-β signaling. A recent study showed a novel role of TGF-β signaling in increased β-cell
replication [81]. Inhibition of TGF-β signaling induced β-cell replication in human islets and adult
mice. We explored the potential miRNA-sponge effect of circRNA-TGFBR3 and found multiple
binding sites for several miRNAs. Two of the top five miRNAs in circRNA-TGFBR3-miRNA network
miR-29a-5p and miR-874-3p have been found to be expressed in human islets and also in α-
and β-cells [69,70]. A discrepancy in the expression of miR-874-3p by miRNA-seq and qPCR based
profiling highlights the technical variation of using different methods. The above two studies detected
141 (out of 667 miRNAs screened by qPCR in six human pancreases) and 346 (small RNA-seq,
three preparations) miRNAs expressed in β-cells. More than 2000 human miRNAs are annotated
so far, therefore, more updated miRNA expression profiling datasets for human α- and β-cells are
needed for better understanding of circRNA–miRNA networks. Interestingly, miR-29a has previously
been found upregulated in INS-1E β-cells by glucose, leading to decreased glucose-stimulated
insulin-secretion [82]. These data suggest that the down regulation of miR-29a by circ-TGFBR3 might
directly affect β-cell function. However, the circRNA-TGFBR3-miRNA-mRNA network needs to be
experimentally validated.
Taken together, these newly identified cell-selective circRNAs in human islets offer new avenues
to explore their functional significance in maintaining β-cell function. Furthermore, the effect of
these cell-selective circRNAs on β-cell proliferation, apoptosis, and insulin secretion also warrants
further investigations.
4. Materials and Methods
4.1. circRNA Identification and Analysis
Total RNA-Seq datasets of FACS sorted human α-, β-, and exocrine cells from 8 diseased
organ donors were retrieved from GEO (GSE50386 and GSE76268). The dataset included libraries
that were single-end sequenced to 100bp on an Illumina hiSeq2000. The SRA accession numbers for all
the samples, sample descriptions, and library sizes are listed in Table S1.
The raw fastq files were trimmed, cropped, and adapters removed using Trimmomatic v.0.36 [83].
A two-step mapping strategy was used as previously described [78] to identify circRNAs. The filtered
reads were first aligned to a human reference genome (GRCh38) using Tophat2.1 [84] with the following
parameters: Library-type = fr-firststrand, no-coverage-search, m 2, p 10. The Tophat-unmapped reads
were then extracted and aligned to a human reference genome (GRCh38) with Tophat-Fusion [85]
using the following parameters: –fusion-search –keep-fasta-order –bowtie1 –no-coverage-search.
The candidate back-spliced junction reads were extracted from Tophat-Fusion alignment and re-aligned
against known gene annotations using CIRCexplorer2 (v.2.2) [63]. Intronic circRNA (ciRNA)
candidates were discarded from the downstream analysis and only exonic circRNAs with ≥2 junctions
spanning reads in at least 1 sample were retained for further analysis. circRNAs expressed
in ≥2 samples with ≥2 junctions spanning reads were categorized as high confidence circRNAs in
each cell-type population. The junction read counts were normalized to log2 transformed read counts
(log2 RC).
For quantification of linear mRNA species, the reads after pre-processing steps (that included
trimming and adapter removal) were aligned to a human genome (GRCh38) using tophat 2.1 [84]
using the following parameters: Library-type = fr-firststrand, no-coverage-search, m 2, p 10. The total
number of reads remaining after QC and percentage of aligned reads for each sample are provided
(Table S1). The raw read counts at gene level were calculated using htseqcount [86] and further
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normalized to counts per million (CPM) and log2 RC in EdgeR [87]. At the transcript level,
Cufflinks v2.2.1 [88] was used to calculate FPKM values. A cutoff of FPKM >1 and expression
in at least 2 samples in each cell-type was used to filter low-expressed transcripts. The distribution of
protein-coding and non-coding transcripts expressed in α-, β-, and exocrine cells is shown in Figure S1.
4.2. Differential Expression Analysis
The circRNAs differentially expressed in β-cells compared to α-cells were identified using
the EdgeR package in R [79]. For this analysis, circRNAs expressed in at least 25% of the samples
and ≥2 junction spanning reads were retained. TMM normalization was applied to this dataset to
account for compositional difference between the libraries. Differentially expressed circRNAs were
identified by likelihood ratio test (glmLRT) in EdgeR using a cutoff of adjusted p-value < 0.05
and absolute log2 fold change (log2 FC) = 1. All the distribution plots, heatmaps, and graphs were
generated in R. The Pearson’s correlations (r) were calculated for circRNAs and their host genes using
log transformed read counts (log2RC). We computed both combined as well as cell-specific correlations
for α- and β-cell samples. Cell-specific correlations were computed for the up and down-regulated
candidates using β-cell and α-cell samples, respectively.
4.3. Functional Annotation of circRNAs
The functional annotation of α- and β-cell selective circRNAs was performed using the ClueGO
plugin in Cytoscape [89]. The host genes for α- and β-cell selective circRNAs were used as proxy
for functional annotation analysis based on GO-BP categories in ClueGO with default parameters.
All human genes were used as background. The p-values were adjusted for multiple correction
using the BH method. The minimum number and minimum percentage of genes to be included
in a group was 5 and 5%, respectively. Similar GO-BP terms were grouped into clusters based on
KappaScore grouping with the following parameters: Kappa Score Threshold = 0.5, Sharing Group
Percentage = 50%.
4.4. miRNA-circRNA Regulatory Network
We created circRNA–miRNA interaction networks using CircNet [67]. CircNet performs
micRNA sponge detection analysis by iteratively searching the circRNA isoforms sequences for
miRNA target sequences with perfect complementarity. The occurrence of miRNA target seeds in
circRNA isoforms are examined and normalized by isoform length. The significance of interactions
is evaluated by referring to the background distribution of miRNA seeds in all transcripts, and only
circRNA-miRNA interactions with p < 0.001 are considered significant. CircNet combines the target
genes of miRNAs from miRTarBase [90], which are also included in networks.
Supplementary Materials: The following are available online at http://www.mdpi.com/2311-553X/4/4/38/s1,
Table S1: Datasets retrieved and analyzed for circRNAs in FACS sorted human islets, Table S2: Full list of high
confidence circRNAs detected in α-, β- and exocrine cells. Table S3: Pearson’s correlation between differentially
expressed circRNAs and host mRNA. Figure S1: Distribution of protein-coding and non-coding transcripts
expressed inα-, β- and exocrine cells. Figure S2: miRNA binding sites for hsa-miR-29a-5p within circRNA-TGFBR3
(ID: 1:91861470:91861644).
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